Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR 0.0130
-0.0014 (-9.72%)
Apr 10, 2026, 5:35 PM CET
Fidia Employees
Fidia had 140 employees as of June 30, 2025.
Employees
140
Change
n/a
Growth
n/a
Revenue / Employee
€150,929
Profits / Employee
€15,657
Market Cap
216.45K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 140 | - | - |
| Dec 31, 2024 | 159 | -34 | -17.62% |
| Dec 31, 2023 | 193 | -4 | -2.03% |
| Dec 31, 2022 | 197 | - | - |
| Jun 30, 2020 | 289 | -42 | -12.69% |
| Mar 31, 2020 | 299 | -32 | -9.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Biesse | 3,723 |
| EuroGroup Laminations | 3,000 |
| SIT S.p.A. | 1,873 |
| Tesmec | 900 |
| ILPRA | 422 |
| Clabo | 324 |
| Marzocchi Pompe | 263 |
| OSAI Automation System | 249 |
Fidia News
- 11 hours ago - IOVA: Analyst Comments on FDA Rejection Impact - GuruFocus
- 12 hours ago - Why Is Plus Therapeutics Stock Gaining Friday? - Benzinga
- 12 hours ago - FDA Again Rejects Replimune Skin Cancer Therapy, Says Evidence Falls Short - Benzinga
- 13 hours ago - Replimune (REPL) Faces Setback as FDA Rejects RP1 Approval Again - GuruFocus
- 13 hours ago - Replimune (REPL) Shares Decline Following FDA Letter - GuruFocus
- 14 hours ago - What's Going On With Replimune Stock Friday? - Benzinga
- 16 hours ago - Telix Pharmaceuticals Shares Jump 7% on FDA Nod for Brain Cancer Imaging Agent Amid Strong Revenue Momentum - International Business Times (Australia)
- 16 hours ago - Telix Seeks Reset With FDA Filing While Sales Growth Holds Steady - Benzinga